Company Overview
- Website
- artemetrx.com
- Phone
- (615) 216-7176
- Employees
- 7
- Founded in
- 2011
- Industry
- Hospital/Clinic
- NAICS Codes
-
456 - Health and Personal Care Retailers51 - Information517 - Telecommunications5171 - Wired and Wireless Telecommunications (except Satellite)51711 - Wired and Wireless Telecommunications Carriers (except Satellite)
- SIC Codes
-
59 - Miscellaneous Retail591 - Drug Stores and Proprietary Stores73 - Business Services737 - Computer Programming, Data Processing, and Other Computer Related7375 - Information Retrieval Services
Financials & Stats
Revenue
$21B
Recent News & Media
Payers Seeking Innovative Solutions to Control Specialty Drug Costs as Pharmacy Benefit Landscape Evolves Rapidly
- Apr 28, 2025
- businesswire.com
Pharmaceutical Strategies Group Launches First-in-Class Technology Solution For Healthcare Payers
- Sep 10, 2024
- businesswire.com
Pharmaceutical Strategies Group Releases Artemetrx State of Specialty Spend and Trend Report
- Jul 25, 2024
- businesswire.com
NEW PRODUCT LAUNCH: Pharmaceutical Strategies Group (PSG) Announces Artemetrx Extend - Revolutionary Drug Management Reporting Tool Offers Powerful User Insights
- Jan 23, 2023
- send2press.com
Spending on Specialty Drugs Maintains Double-Digit Growth
- Sep 1, 2022
- managedhealthcareexecutive.com
Proprietary State of Specialty Spend and Trend Report Released by Pharmaceutical Strategies Group
- Aug 23, 2022
- businesswire.com
Who is Artemetrx
Artemetrx is a privately held company based in Plano, Texas, with 7 employees and $20.8 million in annual revenue. Artemetrx offers an integrated platform designed to analyze data and provide insights into drug spending trends within both pharmacy and medical benefits. Their web-based platform delivers reports, dashboards, and tools aimed at identifying potential drug therapy misuse and areas of overspending. Artemetrx differentiates itself through its extensive 20-year history of expertise in drug management, enabling them to create a platform that simplifies the process of uncovering and addressing drug spend inefficiencies. Visit artemetrx.com for more information.